Description
TGX-221 is an inhibitor of PI3Kβ. It exhibits high selectivity to clear cell renal cell carcinoma with VHL and SETD2 mutations. It also inhibits cell migration and invasion, and induces apoptosis in human glioblastoma cells.
TGX-221 is an inhibitor of PI3Kβ. It exhibits high selectivity to clear cell renal cell carcinoma with VHL and SETD2 mutations. It also inhibits cell migration and invasion, and induces apoptosis in human glioblastoma cells.
Cas No. | 663619-89-4 |
---|---|
Formula | C21H24N4O2 |
Formula Wt. | 364.44 |
IUPAC Name | 9-(1-anilinoethyl)-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one |
Solubility | DMSO 12 mg/mL (32.92 mM) Water Insoluble Ethanol Insoluble |
Appearance | Light Yellow Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Feng C., Sun Y., PI3Kβ inhibitor TGX221 selectively inhibits renal cell carcinoma cells with both VHL and SETD2 mutations and links multiple pathways. Sci Rep. 5:9465 (2015). PMID: 25853938.
Yang X., Yang J., TGX-221 inhibits proliferation and induces apoptosis in human glioblastoma cells. Oncol Rep. 38(5):2836-2842. PMID: 29048665.
PP2A activator, Sphk1 and PKC inhibitor.
Renin inhibitor.
Peptide antigen fragment
EphB4 inhibitor.
Xanthine derivative; adenosine antagonist, PDE ...
Mycotoxin produced by Aspergillus and Penicillu...
Peptide, derivative of AT II, involved in vasoc...
Stilbene, resveratrol analog.
Peptidyl transferase inhibitor, protein transla...
Macrolide; protein translation inhibitor, mamma...
RET, EGFR, VEGFR2 inhibitor.
Tankyrase inhibitor.
Glucose metabolism inhibitor, N-linked glycosyl...
Plasminogen inhibitor.
H+/K+ ATPase inhibitor.
Immunodominant peptide epitope occurring in mul...
α4β2 nAChR desensitizer, delayed-rectifier vo...
Organosulfide found in Allium; cholesterol synt...
G6PDH inhibitor.